Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 185

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Effect of pioglitazone medication on the incidence of dementia

Heneka, Michael T., Fink, Anne, Doblhammer, Gabriele · 2015 · Annals of Neurology

Abstract

Objective: Peroxisome proliferator activated receptor γ–activating drugs show various salutary effects in preclinical models of neurodegenerative disease. The decade‐long clinical usage of these drugs as antidiabetics now allows for evaluation of patient‐oriented data sources. Methods: Using observational data from 2004–2010, we analyzed the association of pioglitazone and incidence of dementia in a prospective cohort study of 145,928 subjects aged ≥60 years who, at baseline, were free of dementia and insulin‐dependent diabetes mellitus. We distinguished between nondiabetics, diabetics without pioglitazone, diabetics with prescriptions of <8 calendar quarters of pioglitazone, and diabetics with ≥8 quarters. Cox proportional hazard models explored the relative risk (RR) of dementia incidence dependent on pioglitazone use adjusted for sex, age, use of rosiglitazone or metformin, and cardiovascular comorbidities. Results: Long‐term use of pioglitazone was associated with a lower dementia incidence. Relative to nondiabetics, the cumulative long‐term use of pioglitazone reduced the dementia risk by 47% (RR = 0.53, p = 0.029). If diabetes patients used pioglitazone <8 quarters, the dementia risk was comparable to those of nondiabetics (RR = 1.16, p = 0.317), and diabetes patients without a pioglitazone treatment had a 23% increase in dementia risk (RR = 1.23, p < 0.001). We did not find evidence for age effects, nor for selection into pioglitazone treatment due to obesity. Interpretation: These findings indicate that pioglitazone treatment is associated with a reduced dementia risk in initially non–insulin‐dependent diabetes mellitus patients. Prospective clinical trials are needed to evaluate a possible neuroprotective effect in these patients in an ageing population. Ann Neurol 2015;78:284–294

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.24439

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 185

Metadata

Authors
Heneka, M. T., Fink, A., & Doblhammer, G.
Venue
Annals of Neurology
Publisher
Wiley
Published
2015-06-30
Volume
78
Issue
2
Pages
284-294
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W1953508171
Cited by
185
References
19
FWCI
16.64
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of pioglitazone medication on the incidence of dementia. https://app.cochat.ai/papers/10.1002/ana.24439
The paper
Heneka, M. T., Fink, A., & Doblhammer, G. (2015). Effect of pioglitazone medication on the incidence of dementia. Annals of Neurology. https://doi.org/10.1002/ana.24439

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.